Lactobacillus reuteri Protectis in a new study on colic

A team of researchers, led by Dr. Marc Rhoads, at the University of Texas Health Science Center in the US have now started a study to investigate the effect of probiotic drops in the treatment of gut inflammation in infants.

"Researchers at the University of Texas Health Science Center are investigating whether a probiotic might help reduce gut inflammation in infants with colic and give families back their peace of mind." - Click2Houston.com

The probiotic mentioned in the article is non other than BioGaia's patented probiotic strain Lactobacillus reuteri Protectis.

The aim of the study is to determine the safety of Lactobacillus reuteri and measure its effect on gut inflammation. The researchers are looking for up to 45 infants between the ages of three weeks and three months to be enrolled in the study. 

Dr. Rhoads says, in the interview with Click2Houston.com, that "If studies in Europe are true we are going to find the babies have less crying time as early as two to three weeks after they start taking them".

See the full interview with Marc Rhoads and parents Leslie and Daniel Ruiz, participating in the study, at Click2Houston.com.